Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 596

2.
3.
4.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
5.

Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial.

Cañas F, Pérez-Solá V, Díaz S, Rejas J; ZIMO Trial Collaborative Group..

Clin Drug Investig. 2007;27(9):633-45.

PMID:
17705572
6.

Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.

Keck PE Jr, Reeves KR, Harrigan EP; Ziprasidone Study Group..

J Clin Psychopharmacol. 2001 Feb;21(1):27-35.

PMID:
11199944
7.

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.

Keck P Jr, Buffenstein A, Ferguson J, Feighner J, Jaffe W, Harrigan EP, Morrissey MR.

Psychopharmacology (Berl). 1998 Nov;140(2):173-84.

PMID:
9860108
8.

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.

Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano RJ, O'Gorman C, Harrigan RH.

Clin Ther. 2010 Mar;32(3):472-91. doi: 10.1016/j.clinthera.2010.03.003.

PMID:
20399985
9.

A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.

Hirsch SR, Kissling W, Bäuml J, Power A, O'Connor R.

J Clin Psychiatry. 2002 Jun;63(6):516-23.

PMID:
12088164
10.

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.

Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP.

Psychopharmacology (Berl). 2001 May;155(2):128-34.

PMID:
11401000
11.
12.

The utility of intramuscular ziprasidone in the management of acute psychotic agitation.

Mendelowitz AJ.

Ann Clin Psychiatry. 2004 Jul-Sep;16(3):145-54.

PMID:
15517847
13.

Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.

Citrome L, Volavka J, Czobor P, Brook S, Loebel A, Mandel FS.

J Clin Psychiatry. 2006 Apr;67(4):638-42.

PMID:
16669729
14.

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.

Daniel DG, Zimbroff DL, Swift RH, Harrigan EP.

Int Clin Psychopharmacol. 2004 Jan;19(1):9-15.

PMID:
15101564
15.

Best clinical practice with ziprasidone IM: update after 2 years of experience.

Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R.

CNS Spectr. 2005 Sep;10(9):1-15. Review.

PMID:
16247923
16.

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.

Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T.

Psychopharmacology (Berl). 2006 Oct;188(3):281-92.

PMID:
16953381
17.

Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.

Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA 3rd, Crandall DT.

J Psychiatr Pract. 2007 May;13(3):170-7.

PMID:
17522560
18.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
19.

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

Olié JP, Spina E, Murray S, Yang R.

Int Clin Psychopharmacol. 2006 May;21(3):143-51.

PMID:
16528136
20.

Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.

Zhang H, Wang G, Zhao J, Xie S, Xu X, Shi J, Deng H, Li K, Gao C, Wang X, Vanderburg D, Pan S, Tang H, Shu L, Karayal ON.

J Clin Psychopharmacol. 2013 Apr;33(2):178-85. doi: 10.1097/JCP.0b013e3182839612.

PMID:
23422376
Items per page

Supplemental Content

Support Center